However, it would be pertinent first to give an overview of our knowledge of the pathophysiology of AF and the physics of cardioversion. Much of what is known about the physics of defibrillation ...

Introduction Improving Immediate Cardioversion Success Maintenance of Sinus Rhythm Following Cardioversion Future Developments/Research References Maintenance of Sinus Rhythm Following ...

A new study published in the journal of Nature Scientific Reports revealed that lactate levels interfere with the electrical ...

Bayer and Janssen's novel oral anticoagulant (NOAC) Xarelto can be used in place of warfarin in atrial fibrillation patients undergoing cardioversion to restore normal heart rhythm, according to a ...

Feasibility study of an objective randomized blinded investigation of therapeutic ablation versus cardioversion for persistent Atrial Fibrillation (ORBITA-AF). Trial objective: Feasibility study of an ...

Feasibility study of an objective randomized blinded investigation of therapeutic ablation versus cardioversion for persistent Atrial Fibrillation (ORBITA-AF). Trial objective: Feasibility study of an ...

Boston Scientific Corporation (NYSE: BSX) today announced data supporting the use of the FARAPULSE™ Pulsed Field Ablation ...

Accessed June 12, 2017. 27. Gorenek B. Cardioversion in atrial fibrillation described: an article from the e-journal of the ESC Council for Cardiology Practice. E-journal of Cardiology Practice.

The larger the left atrium, the higher the risk for AF. Likewise, the larger the left atrium, the less likely that sinus rhythm can be maintained after cardioversion, especially without ...

Looking back, Kokomo resident Mike Beatty knew he had something as a teenager, but he couldn’t put a name to it.